ANN ARBOR — The Advanced Medical Technology Association, or AdvaMed, has named Stephen Rapundalo, president and CEO of MichBio, to chair its State Medical Technology Alliance.
The alliance is a national network of associations representing medical device manufacturers affiliated with AdvaMed. Its mission is to collectively support the industry by fostering a collaborative environment through sharing of best practices and advocating for public policies that support innovation.
MichBio is Michigan’s statewide biosciences trade association.
“As we work with legislators in Congress and in state capitals, it’s critical that we speak with a common voice to reinforce AdvaMed’s advocacy on priority issues affecting the medical technology industry,” said Rapundalo, whose appointment was announced last week during AdvaMed’s annual conference in Washington, D.C. “I look forward to continuing the good work of my predecessors, Heather Erickson of MedTech and Joe Panetta of BIOCOM, and hope the next year is one of many accomplishments.”
“I look forward to Stephen’s leadership as we advance our competitiveness agenda and highlight the important role our industry plays as an engine of medical and economic progress,” AdvaMed President and CEO Stephen J. Ubl said.
MichBio is the trade association committed to driving growth of Michigan’s biosciences industry. MichBio members include biosciences companies, academic and research institutions, biosciences service providers, and related organizations. For more information, visit www.michbio.org.
AdvaMed member companies produce the medical devices, diagnostic products and health information systems that are transforming health care through earlier disease detection, less invasive procedures and more effective treatments. AdvaMed members range from the largest to the smallest medical technology innovators and companies. For more information, visit www.advamed.org.